3 or 4-substituted piperidine compounds

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8513285
APP PUB NO 20120122927A1
SERIAL NO

13353951

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

There are disclosed racemic or enantiomerically enriched 3- or 4-substituted piperidine compounds represented by the following structural formula (I):

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
SK BIOPHARMACEUTICALS CO LTDSEOUL 110-728

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Kim, Won Daejeon, KR 103 313
Lee, Ki-Ho Daejeon, KR 90 985
Min, Kyung-Hyan Daejeon, KR 1 1
Park, Chun-Eung Seoul, KR 6 7
Ryu, Eun-Ju Daejeon, KR 4 5
Shin, Yong-Je Daejeon, KR 4 5
Shin, Yu-Jin Daejeon, KR 11 63
Yoon, Hae-Jeong Daejeon, KR 4 5

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 20, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00